Plante Moran Financial Advisors’s LeMaitre Vascular LMAT Stock Holding History

Plante Moran Financial Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384	Buy	+4	New	+$410	﹤0.01%	1218

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Plante Moran Financial Advisors's LMAT Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 4 shares worth $384. The stake represents ﹤0.01% of the portfolio and ranks #1218 among its holdings.

156 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Plante Moran Financial Advisors held 4 shares of LeMaitre Vascular worth $384 as of Q2 2026.
LeMaitre Vascular was a new Plante Moran Financial Advisors position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1218 holding.
156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.